We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$712B
AUM Growth
+$77.7B
Cap. Flow
+$6.45B
Cap. Flow %
0.91%
Top 10 Hldgs %
29.74%
Holding
13,792
New
1,607
Increased
5,174
Reduced
5,388
Closed
1,330

Top Buys

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.51B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.53B
3
AMZN icon
Amazon
AMZN
+$1.11B
4
ABNB icon
Airbnb
ABNB
+$574M
5
NVDA icon
NVIDIA
NVDA
+$519M

Top Sells

Rank Stock Value
1
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$588M
2
NIO icon
NIO
NIO
+$539M
3
AAPL icon
Apple
AAPL
+$525M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$443M
5
MSFT icon
Microsoft
MSFT
+$375M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 1.94%
2 Technology 1.9%
3 Communication Services 1.42%
4 Financials 1.08%
5 Healthcare 0.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LUXA
11601
PUT
DELISTED
Lux Health Tech Acquisition Corp. Class A Common Stock
LUXA
$184K ﹤0.01%
+18,600
New +$187K
PPBT
11602
PUT
Purple Biotech
PPBT
$2.81M
$183K ﹤0.01%
+187
New +$172K
AVTX icon
11603
CALL
Avalo Therapeutics
AVTX
$1.1B
$182K ﹤0.01%
19
+13
+217% +$109K
LXRX icon
11604
Lexicon Pharmaceuticals
LXRX
$1.03B
$182K ﹤0.01%
+39,576
New +$191K
SPDN icon
11605
PUT
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$216M
$182K ﹤0.01%
11,500
-3,900
-25% -$63.6K
HTPA
11606
DELISTED
Highland Transcend Partners I Corp.
HTPA
$182K ﹤0.01%
18,687
– –
MFGP
11607
DELISTED
Micro Focus International plc. American Depositary Shares, each representing One Ordinary Share
MFGP
$182K ﹤0.01%
+24,122
New +$173K
AHRT
11608
PUT
AH Realty Trust
AHRT
$501M
$181K ﹤0.01%
13,600
-71,900
-84% -$964K
VNRX icon
11609
VolitionRx Ltd
VNRX
$4.89M
$181K ﹤0.01%
2,752
-536
-16% -$36.3K
ARAV
11610
PUT
DELISTED
Aravive, Inc. Common Stock
ARAV
$181K ﹤0.01%
+30,300
New +$160K
RAAS
11611
PUT
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$181K ﹤0.01%
7,133
-222,500
-97% -$6.61M
PFBI
11612
DELISTED
Premier Financial Bancorp
PFBI
$181K ﹤0.01%
+10,737
New +$199K
NHIC
11613
DELISTED
NewHold Investment Corp. Class A Common Stock
NHIC
$181K ﹤0.01%
+18,027
New +$180K
GNLN icon
11614
PUT
Greenlane Holdings
GNLN
$2.08M
– –
0
– –
MIRM icon
11615
Mirum Pharmaceuticals
MIRM
$6.01B
$180K ﹤0.01%
10,411
-2,942
-22% -$52.7K
MMLP icon
11616
PUT
Martin Midstream Partners
MMLP
$86.9M
$180K ﹤0.01%
59,700
+23,700
+66% +$61.9K
JWSM
11617
DELISTED
Jaws Mustang Acquisition Corp.
JWSM
$180K ﹤0.01%
+18,405
New +$182K
OYST
11618
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$180K ﹤0.01%
+10,448
New +$199K
ACCO icon
11619
PUT
Acco Brands
ACCO
$387M
$179K ﹤0.01%
20,700
+5,800
+39% +$51.6K
MREO
11620
PUT
Mereo BioPharma
MREO
$44.4M
$179K ﹤0.01%
56,500
-50,000
-47% -$168K
KDNY
11621
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$179K ﹤0.01%
12,658
-13,409
-51% -$214K
GTYH
11622
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
$179K ﹤0.01%
+25,139
New +$153K
PXLW icon
11623
Pixelworks
PXLW
$41.2M
$178K ﹤0.01%
4,341
-3,250
-43% -$127K
YANG icon
11624
Direxion Daily FTSE China Bear 3X ETF
YANG
$101M
$178K ﹤0.01%
672
-2,116
-76% -$587K
CMRX
11625
PUT
DELISTED
Chimerix, Inc.
CMRX
$178K ﹤0.01%
22,200
-31,600
-59% -$263K
463 464
465
466 467

Similar funds

Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jeff Yass's Q2 2021 Portfolio in Review

As of Q2 2021, Jeff Yass held 13,792 positions worth $712B, up 12% from $634B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Jeff Yass's Q2 2021 filing shows 1,607 new, 5,174 increased, 5,388 reduced and 1,330 closed positions. Its largest new stake was PRA Health Sciences, Inc.: 622,837 shares worth $103M. The largest sale was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $588M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.9% of assets, up from 1.7% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2021 buy was PRA Health Sciences, Inc.: 622,837 shares worth $103M.
  • Jeff Yass added most to Walt Disney in Q2 2021, an estimated $2.51B increase.
  • Jeff Yass's biggest Q2 2021 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $588M.
  • Jeff Yass fully exited iShares Core MSCI EAFE ETF in Q2 2021, selling an estimated $59.3M.
  • Jeff Yass's ten largest holdings make up 30% of its $712B portfolio in Q2 2021.
  • Jeff Yass opened 1,607 new positions and closed 1,330 in Q2 2021.
  • Jeff Yass's portfolio value rose 12% quarter-over-quarter to $712B.

Based on Susquehanna International Group's 13F filing for Q2 2021, filed 11 Aug 2021.